MétaCan
Menu
Back to cohort
Record W4414466429 · doi:10.1097/scs.0000000000011973

Botulinum Toxin A for Improving Cosmetic Outcomes in Facial Wound Healing

2025· article· en· W4414466429 on OpenAlexaffabout
Thamer M. AlBilasi, Reem Mansour Kublan Alkublan, Alanoud S. Bin Suayb, Norah A. Almudawi, Rawan Mahmoud Alanazi, Ahmed Naif Alolaywi, Ahmed Y. Azzam, Philip Solomon

Bibliographic record

VenueJournal of Craniofacial Surgery · 2025
Typearticle
Languageen
FieldMedicine
TopicBotulinum Toxin and Related Neurological Disorders
Canadian institutionsArtificial Intelligence in Medicine (Canada)University of Toronto
Fundersnot available
KeywordsBotulinum toxinDosingWound healingIntervention (counseling)Clinical efficacy

Abstract

fetched live from OpenAlex

INTRODUCTION: Facial wound healing often results in unsatisfactory scarring with significant aesthetic and psychological impact. Botulinum toxin A (BTX-A) has appeared as a promising intervention to improve cosmetic outcomes by reducing muscle tension during wound healing. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of BTX-A in facial wound management. METHODS: We conducted a detailed scientific literature database from inception to 15th of May, 2025, following PRISMA 2020 guidelines. All eligible studies comparing BTX-A with control interventions for facial wound healing were included. Primary outcomes were visual analog scale (VAS) scores and scar width measurements. Secondary outcomes included Vancouver Scar Scale scores, patient satisfaction, and adverse events. Meta-regression investigated dose-response relationships. RESULTS: Fifteen studies with total of 607 participants met inclusion criteria. Botulinum toxin A significantly improved VAS scores (standardized mean difference 0.87, 95% CI: 0.45-1.29, P-value<0.001) and reduced scar width by 0.35 mm (95% CI: -0.52 to -0.18, P-value<0.001). Meta-regression (R²=24%, P-value=0.032) demonstrated a dose-response relationship with effect size increasing by 0.08 SMD units per U/cm. The 5 to 15 U/cm range was identified through safety-efficacy modeling, where doses <5 U/cm showed suboptimal efficacy (SMD 0.65), 5 to 15 U/cm achieved optimal balance (SMD 0.78-1.18, adverse events 1.1%-6.2%), and >15 U/cm showed diminishing returns with increased adverse events. Adverse event rates were comparable between groups (3.9% versus 3.4%, P-value=0.75), with no serious complications reported. CONCLUSIONS: Botulinum toxin A demonstrates significant efficacy in improving facial wound cosmetic outcomes with an excellent safety profile. Evidence-based dosing of 5 to 15 U/cm provides the best benefit-risk ratio. On the basis of cost-effectiveness evaluation of included studies, the intervention demonstrates favorable benefit-risk ratios for wounds in high-visibility facial areas, with economic modeling suggesting better utility for longer wounds where scar prevention outweighs treatment costs.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.006
metaresearch head score (Gemma)0.010
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Bench or experimental · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: none
Teacher disagreement score0.006
Threshold uncertainty score0.031

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0060.010
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0030.009
Bibliometrics0.0020.002
Science and technology studies0.0000.000
Scholarly communication0.0010.001
Open science0.0010.001
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.024
GPT teacher head0.301
Teacher spread0.277 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designBench or experimental
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2025
Admission routes2
Has abstractyes

Explore more

Same venueJournal of Craniofacial SurgerySame topicBotulinum Toxin and Related Neurological DisordersFrench-language works237,207